Blackrock Neurotech, founded in 2008, is a developer of brain-computer interface technology aimed at restoring function for people with disabilities. The company operates at the intersection of neurotechnology, implantable devices, and healthcare. Its work is grounded in extensive human research, including over 19 years of human studies and more than 30,000 days of implant research, which have empowered over 40 individuals.
Central to its offerings is the Utah Array, an implantable brain-computer interface technology used in human studies. The company's broader implantable brain technology decodes neural signals to enable control of external devices and restore sensory feedback, with demonstrated capabilities such as decoding up to 62 words per minute from thought and enabling typing at 90 characters per minute.
The company was founded by long-time friends united by a singular vision to restore hope, with a passionate focus on helping those with paralysis. Its core business sits within the medical devices and neurology industry verticals.